(Q34027595)

30 July 2017

1 reference

title

Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid (English)

1 reference

30 July 2017

main subject

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

primary biliary cholangitis

inferred from title

0 references

author name string

Lee YM

series ordinal

1

1 reference

30 July 2017

Kaplan MM

series ordinal

2

1 reference

30 July 2017

publication date

1 February 1999

1 reference

Current gastroenterology reports

30 July 2017

published in

1 reference

30 July 2017

volume

1

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

38-41

1 reference

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

30 July 2017

cites work

1 reference

12 December 2020

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

12 December 2020

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

1 reference

12 December 2020

Ursodeoxycholic acid for primary sclerosing cholangitis

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study.

1 reference

12 December 2020

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

1 reference

12 December 2020

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

1 reference

12 December 2020

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.

1 reference

12 December 2020

10.1007/S11894-999-0085-4

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1042711082

0 references

Fatcat ID

release_p2fzrpt3rvfnnav7yet2665js4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p2fzrpt3rvfnnav7yet2665js4

24 November 2022

mapped directly with Wikidata item

1 reference